Localized scleroderma in children: Clinical, diagnostic and therapeutic aspects;Esclerodermia localizada na criança: Aspectos clínicos, diagnósticos e terapêuticos

Anais Brasileiros de Dermatologia

Volumn 84, Issue 2, 2009, Pages 161-172

  Zancanaro, Pedro C Q ^a,b   Isaac, Adriana R ^a   Garcia, Luisimara T ^a   Costa, Izelda M C ^a  

^a HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^b SHIS QI   (Brazil)

Author keywords

Child; Childhood; Localized; Review; Scleroderma

Indexed keywords

ANTIMALARIAL AGENT; CALCIPOTRIOL; CALCITRIOL; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOSPORIN; CYTOSINE; IMIQUIMOD; IMMUNOGLOBULIN M; INTERFERON; INTERLEUKIN 13; METHOTREXATE; METHYLPREDNISOLONE; PENICILLAMINE; PREDNISONE; PSORALEN; RETINOID; TACROLIMUS; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA;

BORRELIA BURGDORFERI; CHILD; CLINICAL FEATURE; DRUG DOSE REDUCTION; EOSINOPHILIA; FACE; HISTOPATHOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPERTENSION; KIDNEY INJURY; LABORATORY DIAGNOSIS; LASER DOPPLER FLOWMETRY; LOCALIZED SCLERODERMA; LOW DRUG DOSE; MORPHEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHYSIOTHERAPY; PLASTIC SURGERY; PROGNOSIS; PUVA; REVIEW; THERMOGRAPHY; TRUNK; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ATROPHY; CHILD; DIAGNOSTIC IMAGING; HUMANS; PROGNOSIS; SCLERODERMA, LOCALIZED;

EID: 67449167540     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962009000200009     Document Type: Review

References (77)

1. Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol. 2006;155:1013-1020 (Pubitemid 44564513)
2. Vierra E, Cunningham BB. Morphea and Localized Scleroderma in Children. Semin Cutan Med Surg. 1999;18:210-225 (Pubitemid 29384283)
3. Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol. 1997;24:73-80. (Pubitemid 27059861)
4. Mayes MD. Classification and epidemiology of Scleroderma. Semin Cutan Med Surg. 1998;17:22-26
5. Aberer E, Neumann R, Stanek G. Is localised scleroderma a Borrelia infection? Lancet. 1985;11:278.
6. Aberer E, Stanek G, Ertl M, Neumann R. Evidence for spirochetal origin of circumscribed scleroderma (morphea). Acta Derm Venereol. 1987;67:225-231 (Pubitemid 17084984)
7. Buechner AS, Winkelmann RK, Lautenschlager S, Gilli L, Rufli T. Localized scleroderma associated with Borrelia burgdorferi infection. Clinical, histologic, and immunohistochemical observations. J Am Acad Dermatol. 1993;29(Pt 1):190-196 (Pubitemid 23221896)
8. Wienecke R, Schlüpen EM, Zöchling N, Neubert U, Meurer M, Volkenandt M. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol. 1995;104:23-26
9. Murray KJ, Laxer RM. Scleroderma in children and adolescents. Rheum Dis Clin North Am. 2002;28:603-624
10. Jimenez Sa, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med. 2004;140:37-50. (Pubitemid 38055920)
11. Amento EP. Immunologic abnormalities in scleroderma. Semin Cutan Med Surg. 1998;17:18-21. (Pubitemid 28127885)
12. Yamane K, Ihn H, Kubo M, Yazawa N, Kikuchi K, Soma Y, et al. Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma. J Rheumatol. 2000;27:1917-1921 (Pubitemid 30670486)
13. Liu B, Connolly MK. The pathogenesis of cutaneous fibrosis. Semin Cutan Med Surg. 1998;17:3-11. (Pubitemid 28127883)
14. Kobayasi T, Seup J. Vascular changes in morphea. Acta Derm Venereol. 1985;65:116-120 (Pubitemid 15144834)
15. Roumm AD, Whiteside TL, Medsger TA et al. Lymphocytes in the skin of patients with progressive sclerosis. Quantification, subtyping and clinical correlations. Arthitis Reum. 1984;27:644-653
16. Jimenez SA, Hitraya E, Varga J. Patogénesis of scleroderma: collagen. Rheum Dis Clin North AM. 1996;22:647-674
17. Roberts AB. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab. 1998;24:11-19
18. Peltonen J, Kähäri L, Uitto J, Jimenez SA. Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum. 1990;33:1829-1835
19. Yu B, Eisen A. Scleroderma. In: Freedburg IM, Eisen AZ, Wolff K, et al. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York: McGraw-Hill Internatinal Book Co., 2003. p.1709-1718
20. Leroy EC. Connective tissue synthesis by scleroderma skin fibroblasts in cell culture. J Exp Med. 1972;135:1351-1362
21. Jaworsky C. Connective tissue diseases. In: Elder D, Elenistsas R, Johnson JR B, Murphy GF. Lever's histopathology of the skin. Philadelphia: Lippincott Willians and Wikins; 2005. p. 310-315
22. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol. 2006;18:606-613 Review. (Pubitemid 44607414)
23. Bono W, Dupin N. [Localized scleroderma (morphea)]. Presse Med. 2006;35(Pt 2):1923-1928 French.
24. Guidolin F, Esmanhotto L, Magro CE, Silva MB, Skare TL. Prevalência de achados cutâneos em portadores de esclerose sistêmica -Experiência de um hospital universitário. An Bras Dermatol. 2005;80:481-486 (Pubitemid 46190128)
25. Krafchik BR.Localized cutaneous scleroderma. Semin Dermatol. 1992;11:65-72.
26. Black CM. Prognosis and management of scleroderma and scleroderma-like disorders in children. Clin Exp Rheumatol. 1994;12 Suppl 10:S75-81. Review.
27. Uitto J, Santa Cruz DJ, Bauer EA, Eisen AZ. Morphea and lichen sclerosus et atrophicus. Clinical and histopathologic studies in patients with combined features. J Am Acad Dermatol. 1980;3:271-279 (Pubitemid 11165545)
28. Whittaker SJ, Smith NP, Jones RR. Solitary morphoea profunda. Br J Dermatol. 1989;120:431-440 (Pubitemid 19086633)
29. Kornreich HK, King KK, Bernstein BH, Singsen BH, Hanson V. Scleroderma in childhood. Arthritis Rheum. 1977;20(2 Suppl):343-350
30. Goldenstein-Schainberg C, Pereira RM, Gusukuma MC, Messina WC, Cossermelli W. Childhood linear scleroderma "en coup de sabre" with uveitis. J Pediatr. 1990;117:581-584
31. Muchnick RS, Aston SJ, Rees TD. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmol. 1979;88:889-897 (Pubitemid 10236336)
32. Serup J, Alsbirk PH. Localized scleroderma 'en coup de sabre' and iridopalpebral atrophy at the same line. Acta Derm Venereol. 1983;63:75-77 (Pubitemid 13172553)
33. Holl-Wieden A, Klink T, Klink J, Warmuth-Metz M, Girschick HJ. Linear scleroderma 'en coup de sabre' associated with cerebral and ocular vasculitis. Scand J Rheumatol. 2006;35:402-404
34. Stone J, Franks AJ, Guthrie JA, Johnson MH. Scleroderma 'en coup de sabre': pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry. 2001;70:382-385
35. Blaszczyk M, Królicki L, Krasu M, Glinska O, Jablonska S. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol. 2003;30:1997-2004. (Pubitemid 37075551)
36. Tollefson MM, Witman PM. En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol. 2007;56:257-263 (Pubitemid 46074261)
37. Appenzeller S, Montenegro MA, Dertkigil SS, Sampaio- Barros PD, Marques-Neto JF, Samara AM, Andermann F, Cendes F. Neuroimaging findings in scleroderma en coup de sabre. Neurology. 2004;62:1585-1589 (Pubitemid 38608200)
38. Parodi PC, Riberti C, Draganic Stinco D, Patrone P, Stinco G. Squamous cell carcinoma arising in a patient with long-standing pansclerotic morphea. Br J Dermatol. 2001;144:417-419 (Pubitemid 32178834)
39. Wollina U, Buslau M, Weyers W. Squamous cell carcinoma in pansclerotic morphea of childhood. Pediatr Dermatol 2002;19:151-154 (Pubitemid 34498863)
40. Padilha-Goncalves A. Classificação didática das formas clínicas da esclerodermia. An Bras Dermatol. 1993;68:346-350.
41. Maragh SH, Davis MDP, Bruce AJ, Nelson AM. Disabling pansclerotic morphea: clinical presentation in two adults. J Am Acad Dermatol. 2005;53:S115-9. (Pubitemid 40961823)
42. Pereira LB, Gómez RS, Silva CMR, Santos WF. Você conhece esta síndrome? Síndrome de Parry-Romberg. An Bras Dermatol. 2007;82:90-93
43. Tuffanelli DL. Localized scleroderma. Semin Cutan Med Surg. 1998;17:27-33. (Pubitemid 28127887)
44. Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, et al. Juvenile scleroderma Working Group of the Pediatric Rheumatology European Society (PRES). Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford). 2006;45:614-620
45. Laxera RM, Zulianb F. Localized scleroderma. Curr Opin Rheumatol. 2006;18:606-613 (Pubitemid 44607414)
46. Chung L, Lin J, Furst DE, Fiorentino D. Systemic and localized scleroderma. Clin Dermatol. 2006;24:374-392
47. Sugiura K, Muro Y, Tomita Y. A case of a childhood linear scleroderma with limb asymmetry. Mod Rheumatol. 2004;14:254-256 (Pubitemid 39206673)
48. Takehara K, Sato S. Localized scleroderma is an autoimmune disorder. Rheumatology (Oxford). 2005;44:274-279 (Pubitemid 40361280)
49. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Rheumatoid factor isotypes in localized scleroderma. Clin Exp Dermatol. 2005;30:405-408 (Pubitemid 40835342)
50. Holland KE, Steffes B, Nocton JJ, Schwabe MJ, Jacobson RD, Drolet BA. Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics. 2006;117:e132-6. (Pubitemid 46050511)
51. Martini G, Murray KJ, Howell KJ, Harper J, Atherton D, Woo P, Zulian F, Black CM. Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology (Oxford). 2002;41:1178-1182 (Pubitemid 35203548)
52. Uziel Y, Krafchik BR, Silverman ED, Thorner PS, Laxer RM. Localized scleroderma in childhood: a report of 30 cases. Semin Arthritis Rheum. 1994;23:328-340 (Pubitemid 24116665)
53. Sampaio C, Visentin MT, Howell K, Woo P, Harper J. Morphoea. In: Harper J, Oranje A, Prose N. Textbook of Pediatric Dermatology. 2nd ed. Oxford: Blackwell Publishing; 2006. p.2020-2029 v. 2.
54. Fitch PG, Rettig P, Burnham JM, Finkel TH, Yan AC, Akin E, Cron RQ. Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol. 2006;33:609-614 (Pubitemid 43334587)
55. Emery H. Pediatric scleroderma. Semin Cutan Med Surg. 1998;17:41-47. (Pubitemid 28127889)
56. Hunzelmann N, Scharffetter Kochanek K, Hager C, Krieg T. Management of localized scleroderma. Semin Cutan Med Surg. 1998;17:34-40. (Pubitemid 28127888)
57. Li SC, Liebling MS, Haines KA. Ultrasonography is a sensitive tool for monitoring localized scleroderma. Rheumatology (Oxford). 2007;46:1316-1319 (Pubitemid 47244508)
58. Weibel L, Howell KJ, Visentin MT, Rudiger A, Denton CP, Zulian F, et al. Laser Doppler flowmetry for assessing localized scleroderma in children. Arthritis Rheum. 2007;56:3489-3495 (Pubitemid 47585445)
59. Strauss RM, Bhushan M, Goodfield MJ. Good response of linear scleroderma in a child to ciclosporin. Br J Dermatol. 2004;150:790-792 (Pubitemid 38586248)
60. Hawk A, English JC 3rd. Localized and systemic scleroderma. Semin Cutan Med Surg. 2001;20:27-37.
61. Liu B, Connolly MK. The Pathogenesis of cutaneous fibrosis. Semin Cutan Med Surg. 1988;17:3-11. (Pubitemid 28127883)
62. Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr. 2000;136:91-95 (Pubitemid 30468564)
63. Kreuter A, Gambichler T, Breuckmann F, Rotterdam S, Freitag M, Stuecker M, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol. 2005;141:847-852 (Pubitemid 41058065)
64. Elst EF, Van Suijlekom-Smit LW, Oranje AP. Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children. Pediatr Dermatol. 1999; 16:53-58 (Pubitemid 29102635)
65. Dervis E, Dervis E. Progressive hemifacial atrophy with linear scleroderma. Pediatr Dermatol. 2005;22:436-439 (Pubitemid 43961000)
66. Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol. 1998;39(Pt 1):211-215 (Pubitemid 28367331)
67. Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006;54:440-447 (Pubitemid 43243447)
68. El-Mofty M, Mostafa W, El-Darouty M, Bosseila M, Nada H, Yousef R, et al. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. Photodermatol Photoimmunol Photomed. 2004;20:148-156
69. El-Mofty M, Zaher H, Bosseila M, Yousef R, Saad B. Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed. 2000;16:43-49 (Pubitemid 30230383)
70. De Rie MA, Bos JD. Photochemotherapy for systemic and localized scleroderma. J Am Acad Dermatol. 2000;43:725-726 (Pubitemid 30781537)
71. Pasiç A, Ceoviç R, Lipozenciç J, Husar K, Susiç SM, Skerlev M, et al. Phototherapy in pediatric patients. Pediatr Dermatol. 2003;20:71-77 (Pubitemid 37047177)
72. Kreuter A, Gambichler T, Avermaete A, Jansen T, Hoffmann M, Hoffmann K, et al. Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol. 2001;18:241-245 (Pubitemid 32567879)
73. Grundmann-Kollmann M, Ochsendorf F, Zollner TM, Spieth K, Sachsenberg-Studer E, Kaufmann R, et al. PUVA-cream photochemotherapy for the treatment of localized scleroderma. J Am Acad Dermatol. 2000; 43:675-678 (Pubitemid 30781520)
74. Mancuso G, Berdondini RM. Localized scleroderma: response to occlusive treatment with tacrolimus ointment. Br J Dermatol. 2005;152:180-182 (Pubitemid 40193860)
75. Dytoc M, Ting PT, Man J, Sawyer D, Fiorillo L. First case series on the use of imiquimod for morphoea. Br J Dermatol. 2005;153:815-820 (Pubitemid 41415912)
76. Kreuter A, Altmeyer P, Gambichler T. Treatment of localized scleroderma depends on the clinical subtype. Br J Dermatol. 2007;156:1363-1365 (Pubitemid 47029805)
77. Christen-Zaech S, Hakim MD, Afsar FS, Paller AS. Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol. 2008;59:385-396